PD-L1 antagonist compound
Grant
US12583839B2
Kind: B2
Mar 24, 2026
Assignee
ADLAI NORTYE BIOPHARMA CO., LTD.
Inventors
Zhiyong Yu, Pan Li, Beidi Xu, Yu Zhou, Wei Pang, Qiaodong Wen, Yongqiang Shi, Zhao Sun, Meng Lv
Abstract
Provided are a compound of Formula (I) and a pharmaceutical composition thereof, as well as a method for using the compounds of Formula (I) to prevent and/or treat immune-related disorders.
CPC Classifications
C07D 403/12
C07D 401/12
C07D 401/14
C07D 403/10
C07D 403/14
C07D 405/14
Filing Date
2020-12-22
Application No.
17780979
Claims
19